After 12 months on ART (24-months post-infection), CD4 counts in ART chronically treated individuals remained significantly lower compared to HIV uninfected participants (p=0.001) and the ART hyperacute treated group at 12-months (p=0.008) (Figure 1B). Here, CD4 is linked to infection.